Page last updated: 2024-09-03

sulbactam and Foot Diseases

sulbactam has been researched along with Foot Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Itani, K; Lipsky, BA; Norden, C	1
Gibbons, GW; Grayson, ML; Karchmer, AW; McKinnon, PS; Paladino, JA	1
Abbott, TA; Berger, ML; Dasbach, EJ; Hu, XH; Markson, LE	1

Trials

2 trial(s) available for sulbactam and Foot Diseases

Article	Year
Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jan-01, Volume: 38, Issue:1 Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Diabetes Complications; Drug Therapy, Combination; Foot Diseases; Humans; Linezolid; Oxazolidinones; Sulbactam; Treatment Outcome	2004
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1 Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Drug Costs; Drug Therapy; Drug Therapy, Combination; Foot Diseases; Hospital Costs; Hospitalization; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Penicillins; Protease Inhibitors; Sulbactam; Thienamycins	1997

Article

Year

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jan-01, Volume: 38, Issue:1

Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Diabetes Complications; Drug Therapy, Combination; Foot Diseases; Humans; Linezolid; Oxazolidinones; Sulbactam; Treatment Outcome

2004

Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1

Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Drug Costs; Drug Therapy; Drug Therapy, Combination; Foot Diseases; Hospital Costs; Hospitalization; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Penicillins; Protease Inhibitors; Sulbactam; Thienamycins

1997

Other Studies

1 other study(ies) available for sulbactam and Foot Diseases

Article	Year
Antibiotic therapy for foot infections in diabetics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:6 Topics: Ampicillin; Cilastatin; Cost-Benefit Analysis; Diabetic Foot; Drug Therapy, Combination; Foot Diseases; Humans; Imipenem; Sulbactam	1997